Hemoadsorption in Organ Preservation and Transplantation: A Narrative Review

Overview

Journal Life (Basel)

Specialty Biology

Date 2024 Jan 23

PMID 38255680

Authors

Refugio Garcia-Villegas

Stephan Arni

Affiliations

Soon will be listed here.

Abstract

Cytokine adsorption can resolve different complications characteristic of transplantation medicine, such as cytokine storm activation and blood ABO and immune incompatibilities. Cytokine adsorption is also performed for the treatment of various life-threatening conditions, such as endotoxic septic shock, acute respiratory distress syndrome, and cardiogenic shock, all potentially leading to adverse clinical outcomes during transplantation. After surgery, dysmetabolism and stress response limit successful graft survival and can lead to primary or secondary graft dysfunction. In this clinical context, and given that a major problem in transplant medicine is that the demand for organs far exceeds the supply, a technological innovation such as a hemoadsorption system could greatly contribute to increasing the number of usable organ donors. The objectives of this review are to describe the specific advantages and disadvantages of the application of cytokine adsorption in the context of transplantation and examine, before and/or after organ transplantation, the benefits of the addition of a cytokine adsorption therapy protocol.

References

Bernardi M, Rinoesl H, Dragosits K, Ristl R, Hoffelner F, Opfermann P . Effect of hemoadsorption during cardiopulmonary bypass surgery - a blinded, randomized, controlled pilot study using a novel adsorbent. Crit Care. 2016; 20:96. PMC: 4826492. DOI: 10.1186/s13054-016-1270-0. View

Rybalko A, Pytal A, Kaabak M, Rappoport N, Bidzhiev A, Lastovka V . Case Report: Successful Use of Extracorporeal Therapies After ECMO Resuscitation in a Pediatric Kidney Transplant Recipient. Front Pediatr. 2021; 8:593123. PMC: 7769771. DOI: 10.3389/fped.2020.593123. View

Novelli G, Annesini M, Morabito V, Cinti P, Pugliese F, Novelli S . Cytokine level modifications: molecular adsorbent recirculating system versus standard medical therapy. Transplant Proc. 2009; 41(4):1243-8. DOI: 10.1016/j.transproceed.2009.03.035. View

Calabro M, Febres D, Recca G, Lembo R, Fominskiy E, Scandroglio A . Blood Purification With CytoSorb in Critically Ill Patients: Single-Center Preliminary Experience. Artif Organs. 2018; 43(2):189-194. DOI: 10.1111/aor.13327. View

Schenk H, Muller-Deile J, Schmitt R, Brasen J, Haller H, Schiffer M . Removal of focal segmental glomerulosclerosis (FSGS) factor suPAR using CytoSorb. J Clin Apher. 2017; 32(6):444-452. DOI: 10.1002/jca.21538. View

Rieder M, Duerschmied D, Zahn T, Lang C, Benk C, Lother A . Cytokine Adsorption in Severe Acute Respiratory Failure Requiring Veno-Venous Extracorporeal Membrane Oxygenation. ASAIO J. 2021; 67(3):332-338. DOI: 10.1097/MAT.0000000000001302. View

Lees N, Rosenberg A, Hurtado-Doce A, Jones J, Marczin N, Zeriouh M . Combination of ECMO and cytokine adsorption therapy for severe sepsis with cardiogenic shock and ARDS due to Panton-Valentine leukocidin-positive Staphylococcus aureus pneumonia and H1N1. J Artif Organs. 2016; 19(4):399-402. DOI: 10.1007/s10047-016-0915-8. View

Salvadori M, Tsalouchos A . Therapeutic apheresis in kidney transplantation: An updated review. World J Transplant. 2019; 9(6):103-122. PMC: 6851502. DOI: 10.5500/wjt.v9.i6.103. View

Monard C, Rimmele T, Ronco C . Extracorporeal Blood Purification Therapies for Sepsis. Blood Purif. 2019; 47 Suppl 3:1-14. DOI: 10.1159/000499520. View

10.

Bruenger F, Kizner L, Weile J, Morshuis M, Gummert J . First successful combination of ECMO with cytokine removal therapy in cardiogenic septic shock: a case report. Int J Artif Organs. 2015; 38(2):113-6. DOI: 10.5301/ijao.5000382. View

11.

Nakanishi T, Suzuki N, Kuragano T, Nagasawa Y, Hasuike Y . Current topics in therapeutic plasmapheresis. Clin Exp Nephrol. 2013; 18(1):41-9. DOI: 10.1007/s10157-013-0838-0. View

12.

Song M, Winchester J, Albright R, Capponi V, Choquette M, Kellum J . Cytokine removal with a novel adsorbent polymer. Blood Purif. 2004; 22(5):428-34. DOI: 10.1159/000080235. View

13.

De Rosa S, Marengo M, Fiorentino M, Fanelli V, Brienza N, Fiaccadori E . Extracorporeal blood purification therapies for sepsis-associated acute kidney injury in critically ill patients: expert opinion from the SIAARTI-SIN joint commission. J Nephrol. 2023; 36(7):1731-1742. PMC: 10543830. DOI: 10.1007/s40620-023-01637-5. View

14.

Ankawi G, Fan W, Montin D, Lorenzin A, Neri M, Caprara C . A New Series of Sorbent Devices for Multiple Clinical Purposes: Current Evidence and Future Directions. Blood Purif. 2018; 47(1-3):94-100. DOI: 10.1159/000493523. View

15.

Giuntoli L, Dalmastri V, Cilloni N, Orsi C, Stalteri L, Demelas V . Severe quetiapine voluntary overdose successfully treated with a new hemoperfusion sorbent. Int J Artif Organs. 2019; 42(9):516-520. DOI: 10.1177/0391398819837686. View

16.

Netti G, Sangregorio F, Spadaccino F, Staffieri F, Crovace A, Infante B . LPS removal reduces CD80-mediated albuminuria in critically ill patients with Gram-negative sepsis. Am J Physiol Renal Physiol. 2019; 316(4):F723-F731. DOI: 10.1152/ajprenal.00491.2018. View

17.

Dalmastri V, Angelini A, Minerva V, Ballarini M, Grammatico F, Todeschini P . Extracorporeal hemoadsorption therapy as a potential therapeutic option for rapid removal of Apixaban in high risk-surgical patients: a case report. J Med Case Rep. 2023; 17(1):283. PMC: 10327312. DOI: 10.1186/s13256-023-03949-3. View

18.

Peyneau M, de Chaisemartin L, Faille D, Messika J, Mal H, Castier Y . First Experience With Extracorporeal Cytokine Adsorption Therapy After Lung Transplantation. Transpl Int. 2022; 35:10319. PMC: 8977406. DOI: 10.3389/ti.2022.10319. View

19.

Stahl K, Schmidt B, Hoeper M, Skripuletz T, Mohn N, Beutel G . Extracorporeal cytokine removal in severe CAR-T cell associated cytokine release syndrome. J Crit Care. 2020; 57:124-129. DOI: 10.1016/j.jcrc.2020.02.010. View

20.

Forin E, Lorenzoni G, Ferrer R, De Cal M, Zanella M, Marchionna N . Endotoxin removal therapy with Polymyxin B immobilized fiber column: a single center experience from EUPHAS2 registry. Sci Rep. 2023; 13(1):17600. PMC: 10579294. DOI: 10.1038/s41598-023-44850-9. View